Merus NV (MRUS)
44.03
-0.99
(-2.20%)
USD |
NASDAQ |
May 17, 16:00
44.03
0.00 (0.00%)
After-Hours: 20:00
Merus Cash from Investing (Quarterly): -12.08M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.08M |
| December 31, 2023 | -2.117M |
| September 30, 2023 | 8.022M |
| June 30, 2023 | -24.52M |
| March 31, 2023 | -8.407M |
| December 31, 2022 | 0.856M |
| September 30, 2022 | -1.141M |
| June 30, 2022 | 4.054M |
| March 31, 2022 | -0.967M |
| December 31, 2021 | -15.76M |
| September 30, 2021 | -133.92M |
| June 30, 2021 | 5.727M |
| March 31, 2021 | -2.674M |
| December 31, 2020 | 5.90M |
| September 30, 2020 | -6.108M |
| June 30, 2020 | 2.71M |
| March 31, 2020 | -3.988M |
| December 31, 2019 | 4.148M |
| September 30, 2019 | 4.455M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.714M |
| March 31, 2019 | 7.855M |
| December 31, 2018 | 2.199M |
| September 30, 2018 | -14.93M |
| June 30, 2018 | 6.844M |
| March 31, 2018 | -19.27M |
| December 31, 2017 | -50.31M |
| September 30, 2017 | 0.4101M |
| June 30, 2017 | -0.0674M |
| March 31, 2017 | 0.0342M |
| December 31, 2016 | -0.2586M |
| September 30, 2016 | -0.0415M |
| June 30, 2016 | -0.1211M |
| March 31, 2016 | -0.0079M |
| December 31, 2015 | -0.0377M |
| September 30, 2015 | -0.0158M |
| June 30, 2015 | 0.0107M |
| March 31, 2015 | -0.0152M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-133.92M
Minimum
Sep 2021
8.022M
Maximum
Sep 2023
-8.404M
Average
-1.054M
Median
Cash from Investing (Quarterly) Benchmarks
| uniQure NV | 63.98M |
| ProQR Therapeutics NV | -19.26M |
| argenx SE | -- |
| Pharming Group | 0.664M |
| Pharvaris NV | -0.0334M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.39M |
| Cash from Financing (Quarterly) | 30.16M |
| Free Cash Flow | -150.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7653 |
| Free Cash Flow to Equity (Quarterly) | -44.45M |
| Free Cash Flow to Firm (Quarterly) | -44.45M |
| Free Cash Flow Yield | -6.28% |